Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.55 |
| ▸ | POLB | P06746 | 1/20 | 0.54 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | STING1 | Q86WV6 | 2/20 | 0.49 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | HMGCR | P04035 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL490437 | 0.96 | CYP3A4 (0.56) | NPSR1POLBTAAR1CYP3A4STING1 | |
| SCHEMBL30871956 | 0.96 | CYP3A4 (0.56) | NPSR1POLBTAAR1CYP3A4STING1 | |
| SCHEMBL11331668 | 0.91 | TAAR1 (0.59) | NPSR1POLBTAAR1CYP3A4STING1 | |
| SCHEMBL19953777 | 0.85 | POLB (0.61) | NPSR1POLBCYP3A4IMPDH2LMNA | |
| SCHEMBL27834259 | 0.84 | SLC2A1 (0.56) | NPSR1POLBSTING1LMNAFFAR1 | |
| SCHEMBL14441618 | 0.83 | POLB (0.51) | NPSR1POLBCYP3A4HMGCRFFAR1 | |
| SCHEMBL7820588 | 0.83 | SMN1; SMN2 (0.58) | NPSR1POLBTAAR1CYP3A4LMNA | |
| SCHEMBL8541154 | 0.83 | HPGD (0.47) | NPSR1POLBLMNA | |
| SCHEMBL491188 | 0.82 | HSD17B10 (0.71) | POLBTAAR1HSD17B10 | |
| SCHEMBL4841064 | 0.82 | POLB (0.62) | NPSR1POLBFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9653686-B2 | Organic film transistor, organic semiconductor film, organic semiconductor material and application of these | FUJIFILM CORPORATION (JP) | 2017-05-16 | — | — | US | disclosed |
| US-9653686-B2 | Organic film transistor, organic semiconductor film, organic semiconductor material and application of these | FUJIFILM CORPORATION (JP) | 2017-05-16 | — | — | US | disclosed |
| US-20160126459-A1 | ORGANIC FILM TRANSISTOR, ORGANIC SEMICONDUCTOR FILM, ORGANIC SEMICONDUCTOR MATERIAL AND APPLICATION OF THESE | FUJIFILM CORPORATION (JP) | 2016-05-05 | — | — | US | disclosed |
| US-20160126459-A1 | ORGANIC FILM TRANSISTOR, ORGANIC SEMICONDUCTOR FILM, ORGANIC SEMICONDUCTOR MATERIAL AND APPLICATION OF THESE | FUJIFILM CORPORATION (JP) | 2016-05-05 | — | — | US | disclosed |
| EP-1091958-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2001-04-18 | — | — | EP | disclosed |
| WO-2000001692-A1 | SALTS OF PAROXETINE | SMITHKLINE BEECHAM PLC (GB) | 2000-01-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160126459-A1 | ORGANIC FILM TRANSISTOR, ORGANIC SEMICONDUCTOR FILM, ORGANIC SEMICONDUCTOR MATERIAL AND APPLICATION OF THESE | STRA6, OR10J3, SLC9A1 | NPSR1 3126/4885POLB 3403/4885TAAR1 157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.